Thomson, D.J. et al. 2015. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma. Acta Oncologica. 54, 1 (Jan. 2015), 88–98. DOI:https://doi.org/10.3109/0284186X.2014.958528.